Filter News
Area of Research
- (-) Fusion and Fission (3)
- (-) Materials for Computing (1)
- Biology and Environment (6)
- Clean Energy (3)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion Energy (1)
- Isotopes (24)
- Materials (42)
- National Security (2)
- Neutron Science (10)
- Nuclear Science and Technology (7)
- Quantum information Science (1)
- Supercomputing (34)
News Type
News Topics
- (-) Frontier (1)
- (-) Isotopes (2)
- (-) Physics (1)
- 3-D Printing/Advanced Manufacturing (7)
- Advanced Reactors (6)
- Artificial Intelligence (1)
- Bioenergy (2)
- Biology (2)
- Biomedical (3)
- Buildings (1)
- Chemical Sciences (8)
- Climate Change (1)
- Composites (2)
- Computer Science (8)
- Coronavirus (3)
- Critical Materials (1)
- Decarbonization (3)
- Energy Storage (8)
- Environment (3)
- Exascale Computing (1)
- Fossil Energy (1)
- Fusion (22)
- Grid (2)
- High-Performance Computing (2)
- ITER (6)
- Materials (11)
- Materials Science (18)
- Microscopy (5)
- Nanotechnology (8)
- National Security (1)
- Net Zero (1)
- Neutron Science (6)
- Nuclear Energy (26)
- Partnerships (3)
- Polymers (6)
- Quantum Computing (1)
- Quantum Science (3)
- Security (2)
- Simulation (4)
- Space Exploration (1)
- Summit (1)
- Sustainable Energy (9)
- Transportation (7)
Media Contacts
“Three-Dimensional Breast Cancer Spheroids” submitted by radiotherapeutics researcher Debjani Pal is stunning. Brilliant blue dots pop from an electric sphere threaded with bright colors: greens, aqua, hot pink and red.
As renewable sources of energy such as wind and sun power are being increasingly added to the country’s electrical grid, old-fashioned nuclear energy is also being primed for a resurgence.
Oak Ridge National Laboratory physicist Elizabeth “Libby” Johnson (1921-1996), one of the world’s first nuclear reactor operators, standardized the field of criticality safety with peers from ORNL and Los Alamos National Laboratory.
In experiment after experiment, the synthetic radioisotope actinium-225 has shown promise for targeting and attacking certain types of cancer cells.